by Walter Gunzburg | Nov 19, 2025 | News, Press Release
LAS VEGAS, NEVADA, November 18, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology company focused on developing cell-based therapies for diabetes and age-related disorders, today announced that its 50/50 joint venture...
by Walter Gunzburg | Sep 19, 2025 | News, Press Release
LAS VEGAS, Sept. 18, 2025 /PRNewswire/ — Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and Austrianova (SGAustria Pte. Ltd.), a Singapore-based biotechnology leader, today announced the...
by Walter Gunzburg | Nov 1, 2023 | News, Press Release
Austrianova announces German subsidiary and new location in Singapore SG Austria (“Austrianova”), a leading provider of cell encapsulation, has established a German subsidiary in Munich and moved to a new location in Singapore. SINGAPORE, October 31, 2023...
by Walter Gunzburg | Jun 26, 2023 | News
FIGURE 6. Secretion of IgG from encapsulated clone 6B1 cells. (A). Representative image of capsule four in bright field and fluorescence showing homogenous eGFP expression in encapsulated cells. Encapsulation of clone 6B1 cells. Cells were encapsulated in...
by Walter Gunzburg | Jun 20, 2023 | News
Cell-in-a-Box can be used to protect fragile cells from sheer stress occurring in bioreactors. Products produced by the cells can be easily harvested from the bioreactor since Cell-in-a-Box is a porous structure. Encapsulated cells can also be released from...
by Walter Gunzburg | May 18, 2023 | News, Press Release
This press release can be viewed online at: https://www.einpresswire.com/article/634030792/ The joint treatment will be developed for multiple myeloma, a type of blood cancer that affects plasma cells. SINGAPORE, SINGAPORE, May 18, 2023/EINPresswire.com/ — The...
